This chemical is primarily utilized in the pharmaceutical industry as a key intermediate in the synthesis of various active pharmaceutical ingredients (APIs). Its unique structure, featuring difluoro and fluorophenyl groups, makes it valuable in the development of compounds with enhanced biological activity and metabolic stability. It is often employed in the production of drugs targeting specific enzymes or receptors, particularly in the fields of oncology and neurology. Additionally, its fluorine-containing groups can improve the pharmacokinetic properties of the resulting drug molecules, such as bioavailability and half-life. Researchers also explore its potential in creating novel therapeutic agents for treating complex diseases.